AdvanDx, Inc. today announced that it has entered into a new Multi-Year Agreement with Cedars-Sinai Medical Center. Under the terms of the agreement, Cedars-Sinai Medical Center will incorporate AdvanDx’s rapid PNA FISH tests for definitive identification of S. aureus, C. albicans and E. faecalis directly from positive blood culture bottles.